|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 209/18 | (2006.01) |
| C07D 403/14 | (2013.01) | ||
| C07D 209/04 | (2006.01) | ||
| C07D 417/10 | (2013.01) | ||
| C07D 209/42 | (2006.01) | ||
| C07D 417/12 | (2013.01) | ||
| C07D 265/36 | (2006.01) | ||
| C07D 487/04 | (2013.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 265/36 | (2013.01) | ||
| C07D 417/10 | (2006.01) | ||
| C07D 209/04 | (2013.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 209/18 | (2013.01) | ||
| C07D 209/42 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/425 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 31/00 | (2006.01) |
| (11) | Patento numeris | 3644988 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18822701.1 |
| Europos patento paraiškos padavimo data | 2018-06-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-02-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/039354 |
| Data | 2018-06-25 |
| (87) | Numeris | WO 2019/005698 |
| Data | 2019-01-03 |
| (30) | Numeris | Data | Šalis |
| 201762524829 P | 2017-06-26 | US |
| (72) |
LISANTI, Michael, P. , CA
SOTGIA, Federica , CA
|
| (73) |
Lunella Biotech, Inc. ,
145 Richmond Road, Ottawa, ON K1Z 1A1,
CA
|
| (54) | MITOKETOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING KETONE METABOLISM IN CANCER CELLS |
| MITOKETOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING KETONE METABOLISM IN CANCER CELLS |